Januvia (sitagliptin)

sitagliptin · Merck & Co.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Januvia (sitagliptin), covering 2011-05-09 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas [Phase 2]